Kosuke Ichikawa

802 total citations
19 papers, 542 citations indexed

About

Kosuke Ichikawa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Kosuke Ichikawa has authored 19 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Kosuke Ichikawa's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (5 papers). Kosuke Ichikawa is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (5 papers). Kosuke Ichikawa collaborates with scholars based in Japan and United States. Kosuke Ichikawa's co-authors include Satoshi Watanabe, Hirohisa Yoshizawa, Junta Tanaka, Takao Miyabayashi, Rie Kondo, Jun Koshio, Junko Baba, Ichiei Narita, Hiroshi Kagamu and Hiroshi Tanaka and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Kosuke Ichikawa

16 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kosuke Ichikawa Japan	9	308	181	173	86	72	19	542
Nikolaos Syrigos Greece	12	279 0.9×	187 1.0×	190 1.1×	91 1.1×	76 1.1×	61	599
Domenico Ciliberto Italy	14	415 1.3×	219 1.2×	130 0.8×	116 1.3×	68 0.9×	30	672
Jun Koshio Japan	6	247 0.8×	167 0.9×	125 0.7×	87 1.0×	78 1.1×	11	464
Sally C. M. Lau Canada	13	333 1.1×	124 0.7×	281 1.6×	80 0.9×	45 0.6×	37	529
Pranshu Bansal United States	11	289 0.9×	121 0.7×	218 1.3×	62 0.7×	67 0.9×	21	510
Rie Kondo Japan	12	282 0.9×	209 1.2×	186 1.1×	93 1.1×	160 2.2×	30	714
Bryan A. Faller United States	11	325 1.1×	196 1.1×	179 1.0×	83 1.0×	47 0.7×	32	532
Antonella Ingrosso Italy	14	244 0.8×	192 1.1×	163 0.9×	81 0.9×	100 1.4×	25	635
Thomas Newsom-Davis United Kingdom	12	204 0.7×	233 1.3×	112 0.6×	53 0.6×	128 1.8×	42	516
Vince D. Cataldo United States	8	208 0.7×	200 1.1×	210 1.2×	75 0.9×	56 0.8×	17	520

Countries citing papers authored by Kosuke Ichikawa

Since Specialization

Citations

This map shows the geographic impact of Kosuke Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Ichikawa more than expected).

Fields of papers citing papers by Kosuke Ichikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Ichikawa. The network helps show where Kosuke Ichikawa may publish in the future.

Co-authorship network of co-authors of Kosuke Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Ichikawa. A scholar is included among the top collaborators of Kosuke Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Ichikawa. Kosuke Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Takahashi, Takeshi, et al.. (2026). Pembrolizumab-induced pan–airway mucositis with a cobblestone-like appearance: a case report. Japanese Journal of Clinical Oncology.

Tanaka, Susumu, Koichiro Nozaki, Satoshi Watanabe, et al.. (2025). Risk of lung injury with immune checkpoint inhibitors after talc pleurodesis: A retrospective study. Lung Cancer. 204. 108590–108590.

Koyama, K., Satoru Miura, Satoshi Watanabe, et al.. (2022). Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC. Scientific Reports. 12(1). 6367–6367. 7 indexed citations

Ichikawa, Kosuke, Satoshi Watanabe, Satoru Miura, et al.. (2022). Prognostic significance of procalcitonin in small cell lung cancer. Translational Lung Cancer Research. 11(1). 43–52. 11 indexed citations

Watanabe, Satoshi, Satoshi Shoji, Koichiro Nozaki, et al.. (2022). Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients. Translational Lung Cancer Research. 11(9). 1858–1865. 5 indexed citations

Miura, Satoru, Satoshi Watanabe, Hiroshi Tanaka, et al.. (2021). A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401). Translational Lung Cancer Research. 10(1). 252–260. 6 indexed citations

Ueno, Hiroshi, Masachika Hayashi, Kosuke Ichikawa, et al.. (2020). Disseminated Varicella-zoster Virus Infection Causing Fatal Pneumonia in an Immunocompromised Patient with Chronic Interstitial Pneumonia. Internal Medicine. 60(7). 1077–1082. 8 indexed citations

Watanabe, Satoshi, Takeshi Ota, Masachika Hayashi, et al.. (2020). Prognostic significance of the radiologic features of pneumonitis induced by anti‐PD‐1 therapy. Cancer Medicine. 9(9). 3070–3077. 16 indexed citations

Sato, Miyuki, Satoshi Watanabe, Hiroshi Tanaka, et al.. (2019). Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations. PLoS ONE. 14(4). e0215292–e0215292. 10 indexed citations

10.

Saida, Yu, Satoshi Watanabe, Tetsuya Abe, et al.. (2019). Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases. Thoracic Cancer. 10(11). 2106–2116. 13 indexed citations

11.

Watanabe, Satoshi, Takeshi Ota, Masachika Hayashi, et al.. (2019). Prognostic significance of radiologic features of pneumonitis induced by anti-PD-1 therapy.. Journal of Clinical Oncology. 37(15_suppl). 9065–9065. 4 indexed citations

12.

Kondo, Rie, Satoshi Watanabe, Satoshi Shoji, et al.. (2018). A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer. Oncology. 94(4). 223–232. 38 indexed citations

13.

Sugimoto, Satoru, et al.. (2015). Development of a video image‐based QA system for the positional accuracy of dynamic tumor tracking irradiation in the Vero4DRT system. Medical Physics. 42(8). 4745–4754. 3 indexed citations

14.

Komatsu, Masamichi, Masanori Yasuo, Nobumitsu Kobayashi, et al.. (2015). Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer. Internal Medicine. 54(16). 2045–2049.

15.

Saida, Yu, Satoshi Watanabe, Tomohiro Tanaka, et al.. (2015). Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy. The Journal of Immunology. 195(2). 726–735. 18 indexed citations

16.

Ichikawa, Kosuke, Hiroshi Kagamu, K. Koyama, et al.. (2012). Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity. Vaccine. 30(43). 6190–6197. 5 indexed citations

17.

Baba, Junko, Satoshi Watanabe, Yu Saida, et al.. (2012). Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia. Blood. 120(12). 2417–2427. 57 indexed citations

18.

Watanabe, Satoshi, Junta Tanaka, Takeshi Ota, et al.. (2011). Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis. BMC Cancer. 11(1). 1–1. 329 indexed citations

19.

Miyabayashi, Takao, Hiroshi Kagamu, Jun Koshio, et al.. (2011). Vaccination with CD133+ melanoma induces specific Th17 and Th1 cell–mediated antitumor reactivity against parental tumor. Cancer Immunology Immunotherapy. 60(11). 1597–1608. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact